Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia

21 Jul 2018

Abstract excerpt

Given the heterogeneous nature of frontotemporal dementia (FTD), sensitive biomarkers are greatly needed for the accurate diagnosis of this neurodegenerative disorder. Circulating miRNAs have been reported as promising biomarkers for neurodegenerative disorders and processes affecting the central nervous system, especially in aging. The objective of the study was to evaluate if some circulating miRNAs linked with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30056425
DOI: 10.3233/jad-180364

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal DementiaPMID 30056425Read ↗

Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer’s Disease Pathogenesis by Regulating the Expression of Mitochondrial GenesSemantic proximity Read ↗

Serum Aberrant Expression of miR-24-3P and Its Diagnostic Value in Alzheimer’s DiseaseSemantic proximity Read ↗

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer diseaseSemantic proximity Read ↗

microRNA‐based predictor for diagnosis of frontotemporal dementiaSemantic proximity Read ↗

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read ↗

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targetsSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesSemantic proximity Read ↗

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophySemantic proximity Read ↗

microRNA-based predictor for diagnosis of frontotemporal dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.